Income StatementBalance SheetCash FlowSegments
Pfizer logo

Pfizer Cash Flow Statement

Operating, investing, and financing cash movements

Pfizer generated $12.6B in operating cash flow over the trailing twelve months. After $2.5B in capital expenditures, free cash flow was $12.5B. Free cash flow increased 0.3% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$12.6BNet Cash From Investing (TTM)-$3.8BNet Cash From Financing (TTM)-$8.5BCapital Expenditures (TTM)$2.5BDepreciation And Amortization Cf (TTM)$6.6BNet Change In Cash (TTM)$1.9B
Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$147.62B
P/E Ratio12.19
ROE13.42%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Change in accounts payable-$255.8M-$117.3M-$117.3M-$117.3M-$117.3M—
Change in accounts receivable$27.3M$65.8M$65.8M$65.8M$65.8M—
Change in income taxes payable/receivable-$336.3M-$701.3M-$701.3M-$701.3M-$701.3M—
Change in inventories$213.5M-$140.3M-$140.3M-$140.3M-$140.3M—
Change in other assets-$845.0M-$322.3M-$322.3M-$322.3M-$322.3M—
Change in other liabilities-$778.8M-$916.8M-$916.8M-$916.8M-$916.8M—
Deferred income taxes-$396.0M-$663.0M-$272.0M-$765.0M-$433.0M-$12.0M
Depreciation and amortization$1.8B$1.6B$1.6B$1.7B$1.7B$1.6B
Other Non-Cash Income (Expense)$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Other Non-cash Income (Expense)$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Other Non-cash Income (Expense)$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Net cash from operating activities$6.7B$2.3B$0.0$4.6B$5.3B$2.6B
Net income$418.0M$3.0B$2.9B$3.6B—$2.7B
Other non-cash income (expense)$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Accounts payable-$255.8M-$117.3M-$117.3M-$117.3M-$117.3M—
Income and other taxes-$336.3M-$701.3M-$701.3M-$701.3M-$701.3M—
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital—$1.9B$5.0B$36.0M—$1.7B
Increase (Decrease) in Other Operating Assets-$845.0M-$322.3M-$322.3M-$322.3M-$322.3M—
Other Noncash Income (Expense)$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Other Non-cash Income and Expense$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Gain on Partial Sale of Investment$3.5B$6.3B———$0.0
Pension and Postretirement Contributions Net of Expense—$229.0M$105.0M$84.0M$368.0M$173.0M
Write-offs$3.2B$344.0M$154.0M$366.0M$4.4B$32.0M
Other Non-Cash Adjustments$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Other Non-Cash Income and Expense$1.8B-$40.0M$101.0M$292.0M$117.0M$93.0M
Stock-based compensation$177.0M$170.0M$203.0M$201.0M$225.0M$272.0M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures$917.0M$564.0M$618.0M$602.0M$845.0M$436.0M
Payment for (Proceeds from) Other Investing Activity-$15.0M-$300.0M—-$14.0M—-$22.0M
Payments to Acquire Short-Term Investments$6.2B$2.8B$3.3B$4.2B$4.0B$2.6B
Proceeds from maturities of short-term investments$1.5B$4.0B$6.5B$2.7B$4.7B$4.6B
Proceeds from redemptions/sales of long-term investments$29.0M$82.0M$63.0M$359.0M$591.0M$88.0M
Sales of and distributions from equity method investments$3.5B$6.3B———$0.0
Proceeds from Sale of Equity Method Investments$3.5B$6.3B———$0.0
Proceeds from Sale of Equity Method Investments$3.5B$6.3B———$0.0
Net cash from investing activities—$3.3B$4.0B-$2.4B-$6.1B$785.0M
Proceeds from Partial Sale of Haleon Investment$3.5B$6.3B———$0.0
Net Change in Short-Term Investments (Under 3 Months)-$487.0M$3.9B—$583.0M—$792.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Payments of Ordinary Dividends$2.4B$2.4B$2.4B$2.4B$2.4B$2.4B
Other, net-$14.0M-$356.0M-$21.0M-$38.0M-$43.0M-$284.0M
Short-term borrowings/(repayments) less than 90 days — net—-$386.0M-$517.0M——-$127.0M
Repayments of Short-Term Debt$3.5B$2.0B$151.0M——$0.0
Payment of Deferred Purchase Consideration-$14.0M-$356.0M-$21.0M-$38.0M-$43.0M-$284.0M
Noncontrolling interest transactions and other-$14.0M-$356.0M-$21.0M-$38.0M-$43.0M-$284.0M
Net cash from financing activities-$5.1B-$5.2B-$3.2B-$2.5B$0.0-$2.9B
Noncontrolling Interests Activity and Other-$14.0M-$356.0M-$21.0M-$38.0M-$43.0M-$284.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$5.8B$1.8B—$4.0B$4.5B$2.2B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$29.0M-$7.0M$41.0M$2.0M$5.0M$19.0M
Net increase (decrease) in cash-$45.0M$375.0M$213.0M——$563.0M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Interest paid$1.4B$353.0M$1.1B$275.0M$981.0M$293.0M
Interest Rate Hedges$147.0M$74.0M—$66.0M$45.0M$62.0M
Income Taxes Paid, Net$433.0M$152.0M$3.3B$178.0M$1.0B$72.0M